Form D Explorer

Inspect source fieldsReport a record issue

Form D — AN2 Therapeutics, Inc.

0001880438-26-000001 · filed Mar 25, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$39,999,989
Reported amount sold
$39,999,989
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
AN2 Therapeutics, Inc.
CIK
1880438
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
1300 EL CAMINO REAL, SUITE 100
MENLO PARK, California 94025
Phone
(650) 331-9090

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗